Recursion Pharmaceuticals could benefit from FDA’s AI shift despite risks, with scalable tech and long-term potential. Find ...

ICLR posts mixed results in the first quarter of 2025 due to ongoing clinical development and market volatility.

Mr. Trump instructed the Corporation for Public Broadcasting, which funds public broadcasters in the United States, to end ...

Ubisoft is revamping Assassin's Creed Shadows' parkour system in May with a handful of features, and that's not all the ...

Nvidia's financial health is robust, with consistent earnings beats, strong revenue growth, and significant stock buybacks.

Avoid common mistakes when creating original recipes - learn how to improve flavor, clarity, and consistency for better ...

Ari Bousbib; Chairman of the Board, Chief Executive Officer; IQVIA Holdings Inc Ronald Bruehlman; Chief Financial Officer, Executive Vice President; IQVIA Holdings Inc Thank you for standing by. At ...

Microsoft — Stock in the technology behemoth climbed more than 6% on the heels of better-than-expected third-quarter results ...

First quarter 2025 total revenues increased by 42% to US$79.1 million, compared to the first quarter 2024 RUCONEST® revenue increased by 49% to US$68.6 million, compared to the first quarter 2024, ref ...

Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have ...

This third article in a seven part series presents the Core GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to deciding whether to rate down certainty of evidence ...

Enrollment completed for the 6-week interim analysis with 24 of the 36 planned patients now enrolled Company on track to report interim biomarker data from the first 12 patients imminently Completion ...